Astha Malik
Known title: DirectorCIK: 0002060697
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 11, 2026
Workiva Joins Key S&P Indexes Amid Margin Expansion Focus. Workiva has been added to key S&P indexes, a move that often increases index fund inflows. Recent reports highlight the company's focus on accelerated margin expansion, which analysts see as a key driver for future performance. This development provides context for the stock's current valuation, which remains below the average analyst target price.
Transaction History
| BRZE | ▼ Sell | Open Market | 7,794 | $224K | 8/19/2026 | View on chart |
| BRZE | ▼ Sell | Open Market | 7,530 | $229K | 8/19/2026 | View on chart |
| BRZE | ▼ Sell | Open Market | 400 | $12K | 8/19/2026 | View on chart |
| BRZE | ▼ Sell | Tax Withholding | 21,277 | $616K | 8/17/2026 | View on chart |
| BRZE | ▼ Sell | Open Market | 33,656 | $931K | 8/10/2026 | View on chart |
| BRZE | ▼ Sell | Open Market | 50,233 | $1.3M | 7/15/2026 | View on chart |
| BRZE | ▼ Sell | Open Market | 1,207 | $32K | 7/15/2026 | View on chart |
| WK | ▲ Buy | Grant | 4,070 | — | 6/1/2026 | View on chart |
| BRZE | ▼ Sell | Tax Withholding | 30,263 | $632K | 5/15/2026 | View on chart |
| BRZE | ▲ Buy | Grant | 70,660 | $0 | 3/18/2026 | View on chart |
| BRZE | ▲ Buy | Grant | 117,548 | $0 | 3/18/2026 | View on chart |
| BRZE | ▼ Sell | Open Market | 14,049 | $238K | 2/18/2026 | View on chart |
| BRZE | ▼ Sell | Open Market | 14,322 | $382K | 11/18/2025 | View on chart |
| BRZE | ▼ Sell | Open Market | 3,270 | $106K | 9/5/2025 | View on chart |
| BRZE | ▼ Sell | Open Market | 13,049 | $338K | 8/19/2025 | View on chart |
| BRZE | ▼ Sell | Open Market | 9,001 | $270K | 7/28/2025 | View on chart |
| BRZE | ▲ Buy | Grant | 585 | $15K | 6/16/2025 | View on chart |
| WK | ▲ Buy | Grant | 3,218 | — | 5/29/2025 | View on chart |
| BRZE | ▼ Sell | Open Market | 13,460 | $483K | 5/19/2025 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 11, 2026
Braze Shares Rise Amid Analyst Support and Valuation Focus
Braze stock has seen a recent surge, drawing attention in reports on undervalued tech names. Citizens Bank reiterated a Market Outperform rating with a $35 price target, aligning with the broader analyst consensus of $37.30. This positive sentiment supports the stock's movement within its 52-week range of $15.26 to $37.33.
Braze Shares Rise Amid Analyst Support and Valuation Focus. Braze stock has seen a recent surge, drawing attention in reports on undervalued tech names. Citizens Bank reiterated a Market Outperform rating with a $35 price target, aligning with the broader analyst consensus of $37.30. This positive sentiment supports the stock's movement within its 52-week range of $15.26 to $37.33.